These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3391114)

  • 61. Pharmacology of ticarcillin combined with clavulanic acid in humans.
    Scully BE; Chin NX; Neu HC
    Am J Med; 1985 Nov; 79(5B):39-43. PubMed ID: 4073094
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The prophylactic use of ticarcillin/clavulanate in the neonate.
    Fayed SB; Sutton AM; Turner TL; McAllister TA
    J Antimicrob Chemother; 1987 Jan; 19(1):113-8. PubMed ID: 3558165
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clavulanic acid/antibiotic ratios.
    Rolinson GN
    J Antimicrob Chemother; 1985 Feb; 15(2):256-7. PubMed ID: 3980316
    [No Abstract]   [Full Text] [Related]  

  • 64. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
    Sakai K; Ueda T; Uchino J; Hayasaka A; Shiramatsu K; Nagamachi Y; Shoda Y; Okui K; Hayata Y; Watanabe H
    Jpn J Antibiot; 1987 Apr; 40(4):759-811. PubMed ID: 3302345
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells.
    Garratty G; Arndt PA
    Br J Haematol; 1998 Mar; 100(4):777-83. PubMed ID: 9531349
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of probenecid in ticarcillin-induced hypokalemia.
    Mittal VK; Pierce AK; Priestley JC
    Clin Ther; 1980; 3(2):125-8. PubMed ID: 7448842
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Severe penicillin allergy precipitated by inhalation and topical exposure to co-amoxiclav (Augmentin).
    Jarrett P; Rademaker M
    N Z Med J; 1996 Sep; 109(1030):366. PubMed ID: 8890865
    [No Abstract]   [Full Text] [Related]  

  • 68. Timentin--clinical and pharmacokinetic evaluation in otorhinolaryngology.
    Federspil P; Koch A; Schätzle W; Tiesler E
    J Antimicrob Chemother; 1986 May; 17 Suppl C():103-13. PubMed ID: 3722042
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ticarcillin plus clavulanic acid (Timentin) therapy for osteomyelitis.
    Gentry LO; Macko V; Lind R; Heilman A
    Am J Med; 1985 Nov; 79(5B):116-21. PubMed ID: 4073077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of pelvioperitonitis and Douglas' abscess].
    Matsuda S; Suzuki M; Miyazaki R; Cho N; Kunii K; Fukunaga K; Hayashi S; Nakamura H; Tateno M; Okada H
    Jpn J Antibiot; 1987 May; 40(5):951-68. PubMed ID: 3499526
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of disc-diffusion and plate-incorporation susceptibility testing of gram-negative bacilli to ticarcillin, piperacillin and ticarcillin/clavulanate.
    Elston RA; Swann RA; Fraise A
    J Antimicrob Chemother; 1989 Feb; 23(2):285-7. PubMed ID: 2708186
    [No Abstract]   [Full Text] [Related]  

  • 72. Serum digoxin levels after concomitant ticarcillin and clavulanic acid administration.
    Cazzola M; Matera MG; Santangelo G; Angrisani M; Loffreda A; de Prisco F; Paizis G; Rossi F
    Ther Drug Monit; 1994 Feb; 16(1):46-8. PubMed ID: 8160254
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Timentin in the treatment of post-operative infections.
    McLatchie GR; Williams S; Parameswaran S; Lindsay G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():189-94. PubMed ID: 3636333
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ticarcillin/clavulanate in the treatment of pelvic infections.
    Lucas MJ; Cox SM; Roark ML; Cunningham FG
    J Reprod Med; 1990 Mar; 35(3 Suppl):343-7. PubMed ID: 2181121
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The pharmacokinetics of ticarcillin/clavulanate acid in neonates.
    Fricke G; Doerck M; Hafner D; Horton R; Kresken M
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():111-20. PubMed ID: 2606813
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.
    Zobell JT; Ampofo K; Cash J; Korgenski K; Chatfield BA
    J Cyst Fibros; 2010 Jul; 9(4):280-3. PubMed ID: 20472513
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
    Fujimori I
    Jpn J Antibiot; 1991 Apr; 44(4):365-87. PubMed ID: 1880918
    [No Abstract]   [Full Text] [Related]  

  • 78. [A case of pseudomembranous colitis developing after ticarcillin therapy].
    Suzuki K; Kawamura H; Kishimoto A; Yamamato T; Tomomatsu T; Adachi S; Yamamoto K; Ariga K
    Kansenshogaku Zasshi; 1986 Nov; 60(11):1248-52. PubMed ID: 3102643
    [No Abstract]   [Full Text] [Related]  

  • 79. Ticarcillin and clavulanic acid in serious infections.
    Kosmidis J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():169-75. PubMed ID: 3636332
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacokinetic studies on clavulanate potentiated ticarcillin in normal subjects and patients with renal insufficiency.
    Koeppe P; Höffler D; Hulla FW
    Arzneimittelforschung; 1987 Feb; 37(2):203-8. PubMed ID: 3580024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.